It was found that both 8-Br-cADPR and 78C (an enzyme inhibitor of CD38) could significantly inhibit tumor growth and tumor mass in CD38 WT-LLC-tumor-bearing mice while no therapeutic effects were observed in CD38 KO mice (Fig. 3G). Here, CD38 is linked to neoplasm.